With dermatologic side effects being fairly prevalent following vaccination against COVID‐
19, and the multitude of studies aiming to report and analyze these adverse events, the need …

Monkeypox is a zoonotic disease, endemic in central and west African regions, and has re‐
emerged, currently causing an outbreak as of May 2022. In this systematic review, we aimed …

Most of drugs could have certain mucocutaneous reactions and COVID‐19 drugs are not an
exception that we focused. We systematically reviewed databases until August 15, 2020 and …

As a respiratory viral infection caused by a novel coronavirus, COVID‐19 became rapidly
pandemic within a few months. Despite the wide range of manifestations and organ …

While mucocutaneous manifestations of COVID-19 have been frequently reported and
added to our knowledge every day during the pandemic, another issue is the COVID-related …

In the Coronavirus disease 2019 (COVID-19) pandemic, underlying diseases such as
cardiovascular disease, respiratory illness, liver and kidney disease or malignancies, have a …

The mucocutaneous manifestations of Corona Virus Disease 2019 (COVID‐19) logically
may reflect systemic visceral involvements. These findings are visible and easy to approach …

Objectives Earlier diagnosis and the best management of virus‐related, drug‐related or
mixed severe potentially life‐threatening mucocutaneous reactions of COVID‐19 patients …

Background Tissue fillers are among the most popular cosmetic procedures performed and
notably, cases of filler reactions after COVID‐19 vaccination have been reported. Objective …

Cases of filler reactions after COVID‐19 vaccination have been reported. Here, we present
the first case of delayed‐type reaction (DTR) to non‐hyaluronic acid Polycaprolactone …